1,331
Views
0
CrossRef citations to date
0
Altmetric
Articles; Medical Biotechnology

Hearing impairment in middle-aged patients with diabetes

, , , , &
Pages 737-741 | Received 30 Nov 2015, Accepted 22 Mar 2016, Published online: 12 Apr 2016

References

  • Maia CA, Campos CA. Diabetes mellitus as etiological factor of hearing loss. Braz J Otorhinolaryngol. 2005;71:208–214.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2005;28(Suppl 1):37–42.
  • Frisina ST, Mapes F, Kim S, et al. Characterization of hearing loss in aged type II diabetics. Hear Res. 2006;211:103–113.
  • Robbins SL, Cotran RS, Kumar V. Pathologic basis of disease. In: Membranous glomerulopathy. 3rd ed. Philadelphia (PA): W.B. Saunders Co.; 1991.
  • Nageris B, Hadar T, Feinmesser M, et al. Cochlear histopathogic analysis in diabetic rats. Am J Otol. 1998;19:63–65.
  • Taylor IG, Irwin J. Some audiological aspects of diabetes mellitus. J Laringol Otol. 1978;92:99–113.
  • Friedman SA., Schulman RH, Weiss S. Hearing and diabetic neuropathy. Arch Intern Med. 1975;135:573–576.
  • Miller JJ, Beck L, Davis A, et al. Hearing loss in patients with diabetic retinopathy. Am J Otolaryngol. 1983;4:342–348.
  • Tay HL, Ray N, Ohri R, et al. Diabetes mellitus and hearing loss. Clin Otolaryngol. 1995;20:130–134.
  • Jorgensen MB, Buch NH. Studies on inner-ear and cranial nerves in diabetes. Acta Otolaringol. (Stockh.) 1961;107:179–182.
  • Cruickshanks KJ, Tweed TS, Wiley TL, et al. The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg. 2003;129:1041–1046.
  • Axelsson A, Sigroth K, Vertes D. Hearing in diabetics. Acta Otolaryngol. 1978;85:3–23.
  • Tordjman KM, Yaron M, Izkhakov E, et al. Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism. Eur J Endocrinol. 2010;162:925–933.
  • Gates GA, Cobb JL, D'Agostino RB, et al. The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg. 1993;119:156–161.
  • Bainbridge KE, Hoffman HJ, Cowie CC. Diabetes and hearing impairment in the United States: audiometric evidence from the National Health and Nutrition Examination Surveys, 1999 to 2004. Ann Intern Med. 2008;149:1–10.
  • Kucur C, Kucur SK, Gozukara I, et al. Extended high frequency audiometry in polycystic ovary syndrome. ScientificWorldJournal. 2013;2013:482689.
  • Zeigelboim BS, Mangabeira-Albernaz PL, Fukuda Y. High frequency audiometry and chronic renal failure. Acta Otolaryngol. 2001;121:245–248.
  • Lopes AC, Otubo KA, Basso TC, et al. [Occupational hearing loss: Pure tone audiometry X high-frequency audiometry.] Arquivos Int Otorrinolaringol. 2009;13:631–637. Portuguese.
  • Somma G, Pietroiusti A, Magrini A, et al. Extended high-frequency audiometry and noise induced hearing loss in cement workers. Am J Ind Med. 2008;51:452–462.
  • Mehrparvar AH, Mirmohammadi SJ, Davari MH, et al. Conventional audiometry, extended high-frequency audiometry, and DPOAE for early diagnosis of NIHL. Iran Red Crescent Med J. 2014;16:e9628.
  • Knight KR, Kraemer DF, Winter C, et al. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol. 2007;25:1190–1195.
  • Alberti KG, Zimmet P. Global burden of disease – where does diabetes mellitus fit in? Nat Rev Endocrinol. 2013;9:258–260.
  • Duck SW, Prazma J, Bennett PS, et al. Interaction between hypertension and diabetes mellitus in the pathogenesis of sensorineural hearing loss. Laryngoscope. 1997;107:1596–1605.
  • Lerman-Garber I, Cuevas-Ramos D, Valdés S, et al. Sensorineural hearing loss – a common finding in early-onset type 2 diabetes mellitus. Endocr Pract. 2012;18:549–557.
  • Chasens ER, Enock M, DiNardo M. Reducing a barrier to diabetes education: identifying hearing loss in patients with diabetes. Diabetes Educ. 2010;36:956–964.
  • Panchu P. Auditory acuity in type 2 diabetes mellitus. Int J Diabetes Dev Ctries. 2008;28:114–120.
  • Makishima K, Tanaka AK. Pathological changes of the inner ear and central auditory pathway in diabetes. Ann Otol Rhinol Laryngol. 1971;80:218–228.
  • Fukushima H, Cureoglu S, Schachern PA, et al. Effects of type 2 diabetes mellitus on cochlear structure in humans. Arch Otolaryngol Head Neck Surg. 2006;132:934–938.
  • Yamasoba T, Yoshimoto O, Tsukuda K, et al. Auditory findings in patients with maternally inherit diabetes transfer RNA(Leu) (UUR) gene. Laryngoscope. 1996;106:49–53.
  • Ma F, Gomez-Marin O, Lee DJ, et al. Diabetes and hearing impairment in Mexican American adults: a population-based study. J Laryngol Otol. 1998;112:835–839.
  • Uysal IO, Gok C, Yuce S, et al. [Auditory evaluation in patients with type 2 diabetes mellitus]. Cumhuriyet Med J. 2010;32:85–91. Turkish.
  • Di Leo MAS, Di Nardo W, Cercone S, et al. Cochlear dysfunction in IDDM patients with subclinical peripheral neuropathy. Diabetes Care. 1997;20:824–828.
  • Ottaviani F, Dozio N, Neglia CB, et al. Absence of otoacoustic emissions in insulin-dependent diabetic patients. Is there evidence for diabetic cochleopathy? J Diabetes Complications. 2002;16:338–343.
  • Elamin A, Fadlallah M, Tuvemo T. Hearing loss in children with type 1 diabetes. Indian Pediatr. 2005;42:15–21.
  • Pessin ABB, Martins RHG, Pimenta WDP, et al. Auditory evaluation in patients with type 1 diabetes. Ann Otol Rhinol Laryngol. 2008;117:366–370.